SCIOS INC
10-Q/A, 1996-10-11
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: GATEWAY INDUSTRIES INC /CA/, 10QSB/A, 1996-10-11
Next: ELECTRO SCIENTIFIC INDUSTRIES INC, 10-Q, 1996-10-11





                                   FORM 10-Q/A
                                (Amendment No. 1)

                       SECURITIES AND EXCHANGE COMMISSION

                              Washington, DC 20549

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES  EXCHANGE
ACT OF 1934

For the quarterly period ended June 30, 1996

                                       OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

For the transition period from ________ to ___________

Commission file number: 0-11749


                                   Scios Inc.

                  State or other jurisdiction of (IRS Employer
                incorporation or organization Identification No.)

                               Delaware 95-3701481

                                   Scios Inc.
             2450 Bayshore Parkway, Mountain View, California 94040
                                 (415) 940-6656


         Indicate by check mark whether the registrant (1) has filed all reports
required  to be filed by  Section  13 or 15(d) of the  Securities  Exchange  Act
ofv1934  during the  preceding  12 months (or for such  shorter  period that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days. Yes X No ____

         Indicate the number of shares  outstanding of each of the  registrant's
classes of common stock, as of the latest practicable date.

Title                                                        Outstanding

Common Stock, $.001 par value                                35,931,277



<PAGE>


1. The  Consolidated  Statements  of Cash Flows  contained  in Part I, Item 1 is
hereby  amended in its  entirety  by  substituting  the  following  Consolidated
Statements of Cash Flows:



<PAGE>

                                   SCIOS INC.
                                AND SUBSIDIARIES

                      Consolidated Statements of Cash Flows
                                 (In thousands)

<TABLE>
<CAPTION>

                                                                                      Six months ended
                                                                                          June 30,
                                                                                  1996                1995
                                                                               ------------        -----------

                                                                                        (Unaudited)
<S>                                                                             <C>                 <C>    
Cash flows from operating activities:
   Net loss                                                                      $(15,033)          $(13,223)
   Adjustments to reconcile net loss to net
   cash used by operating activities:
      Depreciation and amortization                                                  2,301              1,749
      Deferred contract revenue                                                    (1,859)              3,672
      Equity in net loss of affiliates                                               1,375              1,658
      Change in assets and liabilities:
        Accounts receivable                                                          (299)              (153)
        Prepaid expenses                                                               104                402
        Other assets                                                                   358                 88
        Accounts payable                                                           (2,585)            (1,787)
        Other accrued liabilities                                                    (673)            (2,307)
                                                                               ------------        -----------
             Net cash used by operating activities                                (16,311)            (9,901)
                                                                               ------------        -----------

Cash flows from investing activities:
   Payments for property and equipment, net                                        (2,070)            (3,964)
   Sales/maturities of marketable securities                                        97,306             87,266
   Purchases of marketable securities                                             (76,544)           (93,220)
                                                                               ------------        -----------
             Net cash provided (used) by investing activities                       18,692            (9,918)
                                                                               ------------        -----------

Cash flows from financing activities:
   Issuance of common stock and collection
   of notes receivable from stockholders, net                                          399                357
   Purchase of treasury stock                                                      (1,455)                 --
   Debt repayments                                                                   (348)              (322)
                                                                               ------------        -----------
             Net cash provided (used) by financing activities                      (1,404)                 35
                                                                               ------------        -----------

Net increase in cash and cash equivalents                                              977           (19,784)
Cash and cash equivalents at beginning of period                                     2,847             29,674
                                                                               ------------        -----------
Cash and cash equivalents at end of period                                         $ 3,824            $ 9,890
                                                                               ------------        -----------

Supplemental cash flow data:
   Cash paid during the period for interest                                         ($307)             ($106)
Supplemental disclosure of non-cash investing
   and financing:
   Net unrealized securities gains (losses)                                          (821)              2,918
   Investment in affiliate                                                         $ 4,708            $ 3,618

</TABLE>

                 See notes to consolidated financial statements.


<PAGE>

                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

SCIOS INC.

/s/ Kevin McPherson
By:________________________________________________
Kevin McPherson
Director of Finance (Acting Chief Accounting Officer)

Date: October 9, 1996



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission